Suscribirse

Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission - 01/09/18

Doi : 10.1016/j.jhin.2018.05.024 
S. Mookerjee a, b, 1, E. Dyakova a, 1, F. Davies a, K. Bamford a, E.T. Brannigan a, A. Holmes a, b, J.A. Otter a, b,
a Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK 
b National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare-Associated Infections (HCAI) and Antimicrobial Resistance (AMR), Imperial College London, Hammersmith Hospital, London, UK 

Corresponding author. Address: Imperial College London, National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare-Associated Infections (HCAI) and Antimicrobial Resistance (AMR), Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. Tel.: +1 020 331 33271.Imperial College LondonNational Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare-Associated Infections (HCAI) and Antimicrobial Resistance (AMR)Imperial College LondonHammersmith HospitalDu Cane RoadLondonW12 0HSUK

Summary

Background

Carbapenem-producing Enterobacteriaceae (CPE) are on the rise worldwide. National guidelines for the prevention and control of CPE recommend screening for the detection of asymptomatic carriers on admission.

Aim

To evaluate the benefit of serial screens for detecting the carriage of CPE and other antibiotic-resistant Gram-negative bacteria following hospital admission.

Methods

All CPE screens, which were cultured on chromogenic media and the presence of a carbapenemase confirmed by polymerase chain reaction, were analysed for a six-month period. National guidelines in England recommend three serial screens for CPE separated by 48 h for admission screening for ‘at-risk’ patients, during which the patient is isolated. Two screening scenarios were tested. In scenario A, patients received three screens at the specified timepoints, in line with English national guidelines; in scenario B, patients received three consecutive screens, but not necessarily within the specified timepoints, during one admission. General linear models or conditional logistic regression were used to detect any significant change in the rate of carriage.

Findings

There was no significant increase in the detected carriage rate of CPE across any of the three timepoints in the scenarios tested. However, there was a significant increase in the detected rate of carriage of Gram-negative bacteria, Enterobacteriaceae, and resistant Enterobacteriaceae (excluding CPE) in scenario B.

Conclusion

Three serial screens were not useful for the detection of CPE carriage on admission. The increase in the carriage rate of other Gram-negative bacteria may be explained by ‘unmasking’ of pre-existing carriage, or acquisition. This argues for regular screening of long-stay patients.

El texto completo de este artículo está disponible en PDF.

Keywords : Carbapenemase-producing Enterobacteriaceae, Carbapenem-resistant Enterobacteriaceae, Gram-negative bacteria, Screening


Esquema


© 2018  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 100 - N° 1

P. 15-20 - septembre 2018 Regresar al número
Artículo precedente Artículo precedente
  • Current strategies to detect, manage and control carbapenemase-producing Enterobacteriaceae in NHS acute hospital trusts in the UK: time for a rethink?
  • G. Winzor, A. Hussain
| Artículo siguiente Artículo siguiente
  • Clinical and molecular epidemiologic characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonization among neonates in China
  • D. Yin, L. Zhang, A. Wang, L. He, Y. Cao, F. Hu, C. Wang

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.